NASDAQ:ELEV Elevation Oncology - ELEV News Today Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Elevation Oncology, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. $1.02 -0.02 (-1.92%) (As of 01/27/2023 12:00 AM ET) Add Compare Share Share Today's Range$1.01▼$1.0450-Day Range$0.75▼$1.1652-Week Range$0.72▼$5.20Volume11,675 shsAverage Volume171,481 shsMarket Capitalization$23.77 millionP/E RatioN/ADividend YieldN/APrice Target$5.83 ProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial Media Get Elevation Oncology News Delivered to You Automatically Sign up to receive the latest news and ratings for ELEV and its competitors with MarketBeat's FREE daily newsletter. Email Address ELEV Media Mentions By Week ELEV Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ELEV News Sentiment▼1.020.72▲Average Medical News Sentiment ELEV News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ELEV Articles This Week▼141▲ELEV Articles Average Week All Sources Trusted Sources MarketBeat.com Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineHow Will Early 2023 Layoffs Affect These 5 Biotech Stocks? (ELEV)marketbeat.com - January 25 at 4:03 AMWedbush Analysts Raise Earnings Estimates for Elevation Oncology, Inc. (NASDAQ:ELEV)americanbankingnews.com - January 27 at 3:16 AMELEV Elevation Oncology, Inc.seekingalpha.com - January 26 at 8:26 AMBrokers Offer Predictions for Elevation Oncology, Inc.'s FY2027 Earnings (NASDAQ:ELEV)americanbankingnews.com - January 26 at 3:44 AMElevation Oncology, Inc. (NASDAQ:ELEV) Short Interest Updateamericanbankingnews.com - January 24 at 6:32 AMElevation Oncology to Present at the 41st Annual J.P. Morgan Healthcare Conferencefinance.yahoo.com - January 9 at 8:02 AMElevation Oncology CEO resigns as part of company prioritization effortmsn.com - January 7 at 7:49 AMElevation Oncology Announces Pipeline Prioritization, Realignment of Resources to Advance EO-3021 and CEO Transitionfinance.yahoo.com - January 6 at 12:40 PMElevation Oncology to Participate at the JMP Securities Hematology and Oncology Summitfinance.yahoo.com - November 30 at 8:25 AMElevation Oncology Reports Third Quarter 2022 Financial Results and Highlights Recent Company Progressfinance.yahoo.com - November 3 at 8:37 AMMerrimack Reports Second Quarter 2022 Financial Resultsfinance.yahoo.com - August 4 at 5:42 PMElevation Oncology to Participate at the Wedbush PacGrow Healthcare Conferencefinance.yahoo.com - August 3 at 10:04 AMElevation Oncology Inc Stock Newsmorningstar.com - July 30 at 5:46 AMElevation Oncology Inc (ELEV)uk.investing.com - July 12 at 9:44 PMShort Volatility Alert: Elevation Oncology, Inc.uk.investing.com - July 12 at 9:44 PMWhy Elevation Oncology Stock Is Risinguk.investing.com - May 27 at 11:36 AMElevation Oncology Inc.barrons.com - May 27 at 6:35 AMElevation Oncology Gets Fast Track Designation for Seribantumab to Treat Tumors Harboring NRG1 Gene Fusionsmorningstar.com - May 27 at 6:35 AMElevation Oncology to Present Initial Seribantumab Proof-of-Concept Data from Phase 2 CRESTONE Study in Patients with Tumors Harboring NRG1 Fusions at ASCO 2022finance.yahoo.com - May 26 at 8:34 PMEstimating The Intrinsic Value Of Elevation Oncology, Inc. (NASDAQ:ELEV)finance.yahoo.com - May 26 at 10:33 AMElevation Oncology Shares Gain On FDA Fast Track Designation For Seribantumab In Tumor-Agnostic Settingsmsn.com - May 25 at 7:26 PMElevation gets FDA fast track status for seribantumab to treat gene-specific solid tumorsseekingalpha.com - May 25 at 9:42 AMElevation Oncology Announces FDA Fast Track Designation Granted to Seribantumab for the Tumor-Agnostic Treatment of Solid Tumors Harboring NRG1 Gene Fusionsfinance.yahoo.com - May 25 at 9:42 AMMerrimack Reports First Quarter 2022 Financial Resultsapnews.com - May 5 at 6:38 PMElevation Oncology Reports First Quarter 2022 Financial Results and Highlights Recent Company Progressfinance.yahoo.com - May 5 at 8:37 AMElevation Oncology Inc - Stock Quote ELEVmorningstar.com - April 29 at 10:26 PMReviR Therapeutics Announces Dr. David Dornan as Independent Board Directormarkets.businessinsider.com - April 28 at 10:45 AMElevation Oncology Announces Initial Data from Phase 2 CRESTONE Study of Seribantumab Selected for Oral Presentation at ASCO 2022finance.yahoo.com - April 27 at 12:38 PMIs Elevation Oncology (NASDAQ:ELEV) In A Good Position To Deliver On Growth Plans?finance.yahoo.com - March 24 at 2:53 PMElevation Oncology Appoints David Dornan, Ph.D., as Chief Scientific Officerfinance.yahoo.com - March 22 at 6:04 AMWedbush Maintains Outperform on Elevation Oncology, Lowers Price Target to $21benzinga.com - March 4 at 2:26 PMElevation Oncology GAAP EPS of -$0.41 beats by $0.18seekingalpha.com - March 3 at 4:51 PMElevation Oncology Reports Fourth Quarter and Full Year 2021 Financial Resultsfinance.yahoo.com - March 3 at 8:15 AMElevation Oncology to Participate at Upcoming Virtual Investor Conferencesfinance.yahoo.com - March 1 at 4:35 PMMerus Announces Financial Results for the Fourth Quarter and Full Year 2021 and Provides Business Updateapnews.com - February 28 at 8:56 PMVertex Ventures HC Announces the Addition of Christine Brennan, Ph.D. as Managing Directorfinance.yahoo.com - February 18 at 1:37 AMElevation Oncology, Inc. Common stock (ELEV)nasdaq.com - January 30 at 8:50 PMElevation Oncology Highlights 2021 Achievements and Outlines Expected 2022 Milestonesfinance.yahoo.com - January 10 at 7:33 AMElevation Oncology to Present at the H.C. Wainwright BIOCONNECT Virtual Conferencefinance.yahoo.com - January 6 at 8:06 AMElevation Oncology to Present at the 40th Annual J.P. Morgan Healthcare Conferencefinance.yahoo.com - January 5 at 10:20 AMElevation Oncology Increuters.com - December 4 at 7:14 PMElevation Oncology to Present at the Piper Sandler 33rd Annual Virtual Healthcare Conferencefinance.yahoo.com - November 18 at 12:57 PMElevation Oncology Reports Third Quarter 2021 Financial Resultsfinance.yahoo.com - November 12 at 8:33 AMElevation Oncology's Seribantumab Included as Part of a Case Series Presentation at the Australasian Gastro-Intestinal Trials Group 2021 Annual Scientific Meetingfinance.yahoo.com - October 14 at 7:20 AMElevation Oncology Inc. Rings the Nasdaq Stock Market Closing Bellnasdaq.com - September 29 at 4:29 PMWe're Hopeful That Elevation Oncology (NASDAQ:ELEV) Will Use Its Cash Wiselynasdaq.com - September 25 at 1:10 PMElevation Oncology (NASDAQ:ELEV) Is In A Good Position To Deliver On Growth Plansfinance.yahoo.com - September 25 at 1:10 PMElevation Oncology to Present at the H.C. Wainwright 23rd Annual Global Investment Conferencefinance.yahoo.com - September 7 at 2:01 PMElevation Oncology Reports Second Quarter 2021 Financial Resultsfinance.yahoo.com - August 12 at 8:22 PMElevation Oncology to Present at the 12th Annual Wedbush PacGrow Healthcare Conferencefinance.yahoo.com - August 4 at 7:38 AMElevation Oncology Announces Pricing of Initial Public Offeringfinance.yahoo.com - July 22 at 8:26 PM Get Elevation Oncology News Delivered to You Automatically Sign up to receive the latest news and ratings for ELEV and its competitors with MarketBeat's FREE daily newsletter. Email Address This page (NASDAQ:ELEV) was last updated on 1/29/2023 by MarketBeat.com Staff Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.